Spesolimab

• Target :

  Interleukin|||IL Receptor

• Related Pathways :

  Immunology/Inflammation

• Purity :

  >95%

• Bioactivity :

  Spesolimab (BI 655130) is an anti-interleukin-36 receptor antibody. It plays a crucial role in the immune system by reducing biomarkers associated with congenital Th1/Th17 and neutrophil pathways. Spesolimab can be used to study systemic pustular psoriasis, palmar and plantar impetigo (PPP), and atopic dermatitis.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2097104-58-8